Skip to main content

CV Sciences debuts +PlusCBD Relief softgels

+PlusCBD Relief softgels are formulated to deliver seven times more CBDA and CBD than the original +PlusCBD raw formula, the company said.
+PlusCBD Relief

CV Sciences is welcoming a brand-new product to its current lineup of CBD offerings.

New from the San Diego-based company are +PlusCBD Relief Softgels, which join previously launched +PlusCBD Sleep and Calm gummies.

[Read More: Are CBD topicals the only way to play?]

Created to deliver seven times more CBDA and CBD than the original +PlusCBD raw formula, the new softgels feature Levagen+ PEA, a CBD-like compound shown by studies to be an alternative to ibuprofen, the company said.

“We believe that +PlusCBD Relief Softgels contain the safest, purest and most effective source of CBD/CBDA available on the market today,” Joseph Dowling, CEO of CV Sciences, said. “Our work at CV Sciences centers around the potential for CBD to transform our understanding of health, wellness and pain relief. The +PlusCBD Relief Softgels represent another step in our mission to offer innovative and safe alternatives to improve health, leveraging CBD/CBDA and PEA.”

[Read More: CV Sciences debuts PlusCBD Pain Relief Topicals line]

By using the aforementioned optimized trio, a healthy inflammatory response and safe alternative in helping manage occasional soreness can be offered to consumers, the company said.

“Our product development team creates best-in-class, innovative products that suit individual preferences, address need states and help consumers benefit from CBD in the way that works best for them,” Dowling said. “Our Relief product is now available directly from our website and soon from select retailers.”

[Read More: NIHC announces effort to strengthen testing standards, CBD labels]

Available in 30-count and six-count bottles, consumers can find +PlusCBD Relief softgels online.

This ad will auto-close in 10 seconds